Pseudomonas Infection in Small Mammals

Quick Facts

🏥 Condition Name
Pseudomonas Infection
📋 Also Known As
Pseudomonas Infection
📂 Category
Infectious Diseases - Bacterial
📁 Subcategory
N/A
🐹 Affects
Multiple body systems including skin, ears, respiratory tract, and urinary system
🏷️ Type
Bacterial
⚠️ Severity
Moderate to Severe
💊 Treatable
Yes, with appropriate antibiotic therapy based on culture and sensitivity
🔄 Contagious
Environmentally acquired, limited direct transmission
🧬 Hereditary
No
🐹 Common In
Chinchillas, guinea pigs, rabbits, hamsters, rats, and mice

Pseudomonas Infection Overview

Pseudomonas infection in small mammals refers to disease caused by bacteria of the genus Pseudomonas, most commonly Pseudomonas aeruginosa, an opportunistic gram-negative pathogen found ubiquitously in the environment. This versatile bacterium thrives in moist environments and can cause a wide range of infections in small mammals, from localized skin and ear infections to serious systemic disease. Pseudomonas is particularly concerning in exotic pet medicine due to its intrinsic resistance to many common antibiotics and its ability to develop additional resistance during treatment, making accurate diagnosis and appropriate antibiotic selection crucial for successful outcomes.

Pseudomonas infections affect multiple small mammal species commonly kept as pets, with chinchillas appearing particularly susceptible to certain presentations. Guinea pigs, rabbits, hamsters, rats, mice, gerbils, and other small rodents all develop Pseudomonas infections under appropriate conditions. The bacteria are environmental organisms rather than obligate pathogens, meaning infection typically occurs when animals are exposed to contaminated water sources, bedding, or environmental surfaces while simultaneously experiencing compromise to their normal defenses through wounds, stress, immunosuppression, or concurrent illness. Outbreaks can occur in breeding facilities or pet stores where contaminated water systems expose multiple animals.

The impact of Pseudomonas infection on small mammal health varies considerably depending on infection site, bacterial strain virulence, and host factors. Localized skin infections may cause relatively minor problems if treated promptly, while ear infections can lead to chronic discomfort and potentially serious complications if infection extends to middle and inner ear structures. Respiratory Pseudomonas infections carry significant morbidity and mortality, particularly given the antibiotic resistance challenges. Systemic infection represents the most serious manifestation, with septicemia carrying high mortality rates in small mammals. The characteristic blue-green pigment produced by many Pseudomonas aeruginosa strains may be visible in wound discharge or on contaminated materials.

Treatment of Pseudomonas infections in small mammals is achievable but requires careful antibiotic selection based on culture and sensitivity testing due to the organism's resistance patterns. Empirical treatment without culture guidance frequently fails due to resistance to commonly used antibiotics. Exotic veterinary expertise is essential for appropriate diagnosis, treatment selection, and monitoring, as species-specific considerations significantly influence therapeutic approaches. Early detection and treatment improve outcomes, though the tendency of small mammals to hide illness often results in delayed presentation. Environmental investigation and remediation are important components of management to prevent reinfection and protect other animals in the household.

Causes of Pseudomonas Infection

Pseudomonas aeruginosa is the predominant species causing disease in small mammals, though other Pseudomonas species occasionally cause infection. This gram-negative bacillus possesses numerous virulence factors contributing to its pathogenicity, including a mucoid capsule that protects against phagocytosis and antibiotics, various toxins that damage host tissues, and enzymes that break down tissue barriers. The bacteria produce characteristic pigments including pyocyanin and pyoverdin that give infected tissues and discharge a distinctive blue-green color. Biofilm formation on surfaces and within tissues protects bacterial populations from both immune responses and antibiotic penetration, contributing to chronic and recurrent infections.

Environmental contamination represents the primary source of Pseudomonas exposure for small mammals. Water sources including drinking bottles, bowls, and humidification systems commonly harbor Pseudomonas, particularly when not cleaned regularly or when water sits stagnant. Sipper tube water bottles are particularly problematic as biofilm develops in the tubes and ball mechanism. Moist bedding creates favorable conditions for bacterial growth. Environmental surfaces in humid areas support Pseudomonas colonization. The bacteria survive well in the environment and can persist on contaminated surfaces for extended periods. Poor hygiene practices facilitate bacterial accumulation and exposure.

Host factors significantly influence susceptibility to Pseudomonas infection. Compromised skin or mucosal barriers from wounds, abrasions, or concurrent infections provide entry points for bacteria. Immunosuppression from stress, malnutrition, concurrent illness, or corticosteroid administration increases vulnerability. Very young and very old animals have less robust immune responses. Animals with underlying chronic diseases face elevated risk. Certain species may have increased susceptibility to specific infection sites, with chinchillas appearing particularly prone to Pseudomonas otitis. Environmental stressors including temperature extremes, overcrowding, and inadequate ventilation compromise host defenses.

Chinchillas demonstrate particular susceptibility to Pseudomonas infections, especially otitis externa and media. The chinchilla ear canal anatomy may contribute to this susceptibility. High environmental humidity, which chinchillas tolerate poorly regardless, also favors Pseudomonas growth. Dust bathing if contaminated dust is used could theoretically introduce bacteria to ear canals. Stress from improper husbandry, social disruption, or environmental factors increases chinchilla susceptibility to various infections including Pseudomonas. Other species develop Pseudomonas infections less frequently but are not immune, with infection occurring particularly in compromised individuals or with heavy environmental contamination.

The pathophysiology of Pseudomonas infection involves bacterial colonization of susceptible tissues followed by local multiplication, tissue invasion, and inflammatory response. Initial colonization may occur without immediate disease, with progression to clinical infection when conditions favor bacterial proliferation or host defenses weaken. Local tissue damage results from bacterial toxins and enzymes as well as the host inflammatory response. Chronic infections often involve biofilm formation that protects bacteria within a matrix of extracellular material, making eradication difficult. Systemic spread may occur through lymphatic or hematogenous routes, leading to bacteremia and seeding of distant organs. The severity of disease depends on bacterial load, strain virulence, infection site, and host immune competence.

Symptoms & Warning Signs

Early warning signs of Pseudomonas infection vary depending on the affected body system but often include subtle behavioral changes that precede obvious physical symptoms. Animals may show decreased activity or slightly reduced appetite before localized signs become apparent. Increased attention to a particular body area through scratching, rubbing, or grooming may indicate developing skin or ear problems. Mild discharge that owners might initially overlook can represent early infection. Changes in water consumption patterns might indicate developing illness. Recognition of these subtle changes allows earlier veterinary intervention and improved outcomes, though the nonspecific nature makes definitive early identification challenging.

Skin infections caused by Pseudomonas typically present as moist, weeping lesions often with characteristic blue-green discoloration of the discharge due to bacterial pigment production. Affected areas may appear red, swollen, and painful. Fur loss around infected areas is common. Lesions may develop crusting as discharge dries. In severe cases, deep ulceration and tissue necrosis can occur. Abscess formation is possible, with fluctuant swellings developing at infection sites. Skin infections often develop at sites of previous wounds, abrasions, or other skin compromise. The blue-green coloration, when present, provides a strong clinical clue to Pseudomonas involvement.

Ear infections represent a common manifestation of Pseudomonas in small mammals, particularly chinchillas. Affected animals often display head shaking, ear scratching, and rubbing the affected ear against surfaces. Discharge from the ear canal may be visible and often has blue-green coloration. Pain response when the ear is touched indicates otitis. Head tilt may develop if infection extends to middle and inner ear structures. Facial nerve involvement can cause drooping of facial muscles on the affected side. Balance problems including circling, rolling, or ataxia indicate vestibular involvement from inner ear extension. Ear infections may be unilateral or bilateral.

Behavioral and systemic signs accompany more serious Pseudomonas infections. Animals with significant localized infections show decreased activity and reduced appetite. Pain from infected areas causes changes in posture or reluctance to move normally. Social withdrawal occurs in species that normally seek interaction. Grooming behavior may increase around affected areas or decrease overall if the animal feels generally unwell. Signs of systemic infection include lethargy, complete anorexia, fever or hypothermia, and general deterioration. Weight loss develops with prolonged infection due to decreased intake and increased metabolic demands.

Symptom progression depends on infection site and host factors. Superficial skin infections may remain localized for extended periods or may spread and deepen without treatment. Ear infections typically progress from external ear involvement to middle ear and potentially inner ear over days to weeks, with vestibular signs indicating deep extension. Respiratory infections may progress rapidly to pneumonia. Systemic spread can occur from any primary site, with rapid deterioration once bacteremia develops. Small mammals with limited physiological reserves deteriorate quickly once systemic infection occurs, with timeline measured in hours to days rather than days to weeks.

Emergency symptoms requiring immediate veterinary intervention include signs of systemic infection or sepsis such as extreme lethargy, cold extremities, collapse, or altered mentation. Severe vestibular signs including inability to maintain balance, continuous rolling, or complete disorientation indicate serious inner ear involvement requiring urgent treatment. Respiratory distress from Pseudomonas pneumonia constitutes an emergency. High fever or marked hypothermia suggests systemic infection. Any animal showing rapid deterioration should receive emergency care from a veterinarian experienced in exotic small mammal medicine, with understanding that prognosis for severe systemic Pseudomonas infection is guarded.

Diagnosis

Diagnosis of Pseudomonas infection requires thorough physical examination by a veterinarian experienced in exotic small mammal medicine, with careful attention to potential infection sites. Skin lesions are evaluated for extent, depth, and characteristic appearance. Ear examination using otoscope assesses the ear canal and tympanic membrane status. Respiratory auscultation identifies lower respiratory involvement. Overall systemic status is evaluated including hydration, body condition, and vital parameters. The distinctive blue-green pigmentation of discharge, when present, provides a strong presumptive indicator of Pseudomonas involvement, though confirmation requires laboratory testing.

Culture and sensitivity testing is essential for Pseudomonas infections given the organism's variable and often extensive antibiotic resistance. Samples from infected sites including wound swabs, ear discharge, or respiratory secretions are submitted for aerobic bacterial culture. Pseudomonas aeruginosa grows readily on standard laboratory media and produces characteristic pigments that aid identification. Sensitivity testing determines which antibiotics will effectively treat the specific isolate, as resistance patterns vary considerably between strains. Results typically require two to five days, during which empirical therapy may be initiated based on known Pseudomonas susceptibility patterns, with adjustment once results are available.

Additional diagnostic testing supports comprehensive evaluation and treatment planning. Complete blood count may reveal elevated white blood cell count indicating infection, or may show other changes in severe systemic disease. Blood chemistry panels assess organ function, particularly important if nephrotoxic antibiotics are being considered. Radiographs may be indicated for suspected respiratory involvement or to evaluate extent of disease in ear infections. Cytology of discharge samples can reveal bacterial morphology and inflammatory cells. In severe cases, blood culture may identify septicemia. Species-specific reference ranges must be applied when interpreting laboratory results.

Differential diagnosis for Pseudomonas infection includes other bacterial pathogens and non-infectious conditions depending on presentation. Skin infections may result from Staphylococcus, Streptococcus, Pasteurella, or other bacteria, as well as fungal organisms or parasites. Ear infections have multiple potential causes including ear mites, yeast infections, and other bacterial species. Respiratory disease may result from various viral, bacterial, and other pathogens. The blue-green discharge coloration, when present, strongly suggests Pseudomonas, but culture confirmation is required for definitive diagnosis and to guide appropriate antibiotic selection. Mixed infections with multiple organisms do occur and may be identified on culture.

Treatment Options

Emergency treatment of severe Pseudomonas infections focuses on patient stabilization while awaiting culture results to guide definitive antibiotic therapy. Fluid therapy addresses dehydration common in sick small mammals and supports cardiovascular function in septic patients. Temperature regulation maintains patients within appropriate range, as both hypothermia and hyperthermia may occur. Nutritional support through syringe feeding begins immediately for anorexic patients. Oxygen supplementation may be needed for respiratory involvement. Pain management improves patient comfort. Empirical antibiotic therapy may begin with agents likely to have activity against Pseudomonas while awaiting sensitivity results.

Antibiotic selection for Pseudomonas infections must account for this organism's extensive intrinsic and acquired resistance mechanisms. Aminoglycosides including gentamicin and amikacin often retain activity against Pseudomonas and may be used systemically or topically depending on infection site. Fluoroquinolones including enrofloxacin and marbofloxacin have activity against many Pseudomonas strains. Third-generation cephalosporins and carbapenems may be effective but are not commonly used in small mammal practice. Topical therapy with appropriate agents may be effective for localized skin or ear infections. Culture-guided selection is strongly recommended given variable resistance patterns. Treatment duration typically extends three to six weeks depending on infection severity and site.

Local treatment of skin infections includes wound cleaning, debridement of necrotic tissue, and topical antimicrobial application. Silver sulfadiazine cream has activity against Pseudomonas and is commonly used for wound management. Dilute chlorhexidine or povidone-iodine solutions may be used for wound flushing. Bandaging may protect wounds and maintain topical medications in contact with affected tissue. For abscesses, surgical drainage or excision followed by wound management is typically required. Systemic antibiotics complement local therapy for significant skin infections.

Ear infection treatment depends on disease extent and may include topical therapy alone for superficial otitis externa or combined systemic and topical treatment for deeper infections. Topical preparations containing appropriate antibiotics, often combined with anti-inflammatory agents, are applied to the ear canal. Ear cleaning may be necessary to remove debris and allow medication contact with infected tissue, though this must be performed carefully to avoid damaging the tympanic membrane. Middle and inner ear infections require systemic antibiotic therapy and carry more guarded prognosis. Surgical intervention may be considered for severe or refractory cases.

Species-specific treatment considerations influence therapeutic approaches. Chinchilla Pseudomonas otitis may require prolonged treatment and carries risk of chronic or recurrent disease. Guinea pig treatment must include vitamin C supplementation to support immune function. Rabbit gut flora sensitivity must be considered when selecting systemic antibiotics. Small rodent species have limited blood volume for monitoring and narrow margins for dosing errors. Aminoglycoside nephrotoxicity requires particular caution in species with limited ability to monitor renal function. Stress from treatment procedures must be weighed against therapeutic benefits.

Treatment challenges in Pseudomonas infections center on antibiotic resistance and chronic infection patterns. Empirical therapy frequently fails due to resistance, emphasizing the importance of culture-guided treatment. Biofilm formation in chronic infections protects bacteria from both antibiotics and immune responses. Ear infections may become chronic with recurrent flares despite treatment. Environmental recontamination can cause reinfection after successful treatment. Cost of prolonged antibiotic courses and repeated cultures may challenge owner resources. Some infections prove refractory to available treatments despite appropriate antibiotic selection based on sensitivity testing.

Recovery & Prognosis

Recovery timeline from Pseudomonas infection varies substantially based on infection site, severity, and individual patient factors. Superficial skin infections may show improvement within one to two weeks of initiating appropriate therapy, with complete healing over three to four weeks. Ear infections typically require longer treatment, often four to six weeks minimum, with some cases requiring extended or intermittent long-term therapy. Deep tissue infections and systemic disease require the longest treatment courses and recovery periods. Some infections, particularly chronic ear infections, may never fully resolve and instead require ongoing management to control clinical signs.

Post-treatment monitoring ensures adequate treatment response and detects early recurrence. Follow-up veterinary examinations assess clinical improvement and may include repeat cultures to document bacterial clearance. Owners should monitor for return of clinical signs following treatment completion. Weight tracking ensures adequate nutrition during recovery. For ear infections, ongoing attention to ear appearance and behavior for signs of discomfort helps detect recurrence early. Animals successfully treated for Pseudomonas should have their environment thoroughly cleaned and water sources evaluated to prevent reinfection from environmental reservoirs.

Prognosis factors influencing outcomes include infection site, with superficial localized infections carrying better prognosis than deep or systemic disease. Antibiotic sensitivity pattern affects treatability, with multi-drug resistant strains having poorer outcomes. Early presentation before extensive tissue damage or systemic spread improves prognosis. Host factors including overall health status and immune competence influence ability to clear infection with antibiotic support. Response to initial therapy provides prognostic information, with animals showing improvement within the first week having better outcomes than those failing to respond. Owner compliance with prolonged treatment courses affects success rates.

Long-term outlook depends on achieving bacterial clearance versus developing chronic managed disease. Many animals achieve complete resolution of Pseudomonas infections with appropriate treatment and environmental remediation. Chronic infections, particularly ear infections in chinchillas, may require ongoing management with intermittent treatment during flares. Some animals retain susceptibility to recurrence and may develop repeat infections if re-exposed to environmental Pseudomonas. Quality of life for animals with chronic Pseudomonas ear infections can often be maintained with appropriate management, though some cases progress to cause permanent vestibular damage affecting balance. Environmental improvements following infection help prevent recurrence and protect any other animals in the household.

Prevention

Water source management forms the cornerstone of Pseudomonas prevention, as contaminated water represents the most common source of exposure. Water bottles should be emptied, thoroughly cleaned, and refilled with fresh water daily. Sipper tubes require particular attention as biofilm develops readily in these components. Bottles should be replaced periodically as scratches and wear create areas where bacteria can accumulate. Water bowls, if used, require daily changing and cleaning. For facilities using automated watering systems, regular system flushing and sanitation protocols are essential. Water quality testing may be appropriate in breeding facilities or following Pseudomonas outbreaks.

Environmental hygiene reduces bacterial load and exposure risk. Regular thorough cleaning of enclosures removes organic matter that supports bacterial growth. Bedding should be kept dry and changed regularly. Humidity control is important, particularly for chinchillas, as high humidity favors Pseudomonas growth while also being independently harmful to chinchillas. Cleaning supplies should be stored properly to prevent contamination. Surfaces should be dried after cleaning, as residual moisture supports bacterial growth. Isolation and enhanced hygiene practices should be implemented if Pseudomonas infection is diagnosed in any animal in a multi-pet household.

Stress reduction supports immune function and disease resistance. Species-appropriate housing provides adequate space, appropriate temperature, and suitable environmental complexity. Social needs should be met with compatible companions for social species or appropriate solitude for solitary species. Handling should be gentle and appropriate, avoiding unnecessary stress. Stable routines and environments reduce chronic stress. Loud noises, strong odors, and exposure to predator species should be minimized. Any unavoidable stressors should be accompanied by enhanced monitoring for developing illness.

Health maintenance through proper nutrition supports immune competence. Complete, species-appropriate diets provide nutritional foundation for immune function. Guinea pigs require adequate vitamin C, as deficiency impairs immunity. Fresh, high-quality food prevents exposure to bacteria that might colonize contaminated items. Clean water supports overall health. Appropriate body condition should be maintained, avoiding both obesity and underweight. Treats should be given in moderation and should not replace balanced nutrition.

Veterinary involvement supports prevention through health monitoring and early intervention. New animal examinations identify existing health problems and provide baseline health assessment. Regular wellness examinations detect early signs of infection before significant progression. Prompt attention to any wounds or skin breaks allows treatment before secondary infection develops. Any signs of ear problems should prompt veterinary evaluation to address infections before they become chronic. Following diagnosis of Pseudomonas in any animal, environmental investigation and remediation should occur to identify and eliminate the exposure source.

Living With & Managing Pseudomonas Infection

Daily care requirements for animals being treated for or recovering from Pseudomonas infection emphasize medication compliance and environmental management. Antibiotics must be administered on schedule for the entire prescribed duration, which typically extends several weeks. Topical treatments require consistent application following proper technique. Daily observations should assess treatment response including wound appearance for skin infections, ear discharge and behavior for otitis, and overall activity and appetite. Clean, dry bedding should be maintained with frequent changes. Fresh, uncontaminated water must be available at all times from properly maintained sources.

Environmental management focuses on eliminating Pseudomonas reservoirs and preventing reinfection. Water delivery systems require thorough cleaning and potentially replacement of contaminated components. Daily water bottle maintenance must become routine. Humidity should be maintained at appropriate levels for the species, avoiding the high humidity that favors Pseudomonas growth. Cage and enclosure cleaning should be thorough and regular. Items that cannot be adequately cleaned should be replaced. Other animals in the household should be monitored for signs of infection and should not share water sources or housing with infected animals until treatment is complete.

Monitoring health indicators tracks treatment response and detects complications or recurrence. For skin infections, wound appearance should improve progressively with decreased discharge, reduced inflammation, and granulation tissue formation. Ear infections should show decreased discharge, reduced pain response, and resolution of any vestibular signs. Body weight should stabilize and then improve as appetite returns. Activity levels should increase as animals feel better. Any worsening of signs during treatment requires veterinary reassessment and potentially culture repeat to detect resistance development or secondary infection.

Quality of life considerations guide ongoing management, particularly for chronic infections. Animals should maintain appetite and interest in normal activities between treatment periods. Pain should be well controlled. Animals with chronic ear infections and vestibular damage may adapt remarkably well to balance deficits. Treatment intensity should be balanced against stress of interventions. Chronic infections that cannot be cured but can be managed should be reassessed periodically to ensure quality of life remains acceptable. Clear communication with veterinary team helps establish expectations and decision points.

Caregiver support addresses the challenges of managing Pseudomonas infections, particularly chronic or recurrent cases. Exotic veterinarians provide guidance on treatment protocols and environmental remediation. Cost planning for prolonged antibiotic courses and potential repeated cultures helps ensure consistent treatment. Owner education about proper water bottle maintenance and environmental hygiene supports prevention of recurrence. Emotional support may be needed for owners dealing with chronic illness in their pets. Online communities may provide practical tips and encouragement from others who have managed similar infections. Understanding that some infections become chronic managed conditions rather than cured diseases helps set appropriate expectations.

Species at Risk for Pseudomonas Infection

Chinchillas demonstrate particular susceptibility to Pseudomonas infections, especially otitis externa and media, earning this species recognition as a high-risk population for this pathogen. Multiple factors may contribute to chinchilla susceptibility including ear canal anatomy, the species' sensitivity to humidity which also favors Pseudomonas growth, and possibly characteristics of chinchilla skin or immune responses. Pseudomonas otitis in chinchillas tends to be challenging to treat and may become chronic with recurrent episodes. Young chinchillas and those in breeding facilities or pet stores may face elevated risk due to stress and potential environmental contamination. The combination of chinchilla care requirements and Pseudomonas prevention measures fortunately overlap, as both require low humidity environments.

Guinea pigs develop Pseudomonas infections with moderate frequency, often in association with skin wounds, ear infections, or respiratory disease. Vitamin C deficiency increases susceptibility by impairing immune function, making dietary adequacy particularly important for Pseudomonas prevention in this species. Guinea pigs housed in groups may face increased risk if one animal develops infection and contaminates shared water sources. Young guinea pigs and those in stressful environments show increased susceptibility. The species' relatively docile nature facilitates treatment compliance compared to some other small mammals.

Other small mammal species develop Pseudomonas infections less commonly but are not immune to this opportunistic pathogen. Rabbits may develop Pseudomonas wound infections or otitis, though they appear less susceptible than chinchillas to ear infections from this organism. Hamsters can develop various Pseudomonas infections but are limited in treatment options due to antibiotic sensitivities. Rats and mice develop Pseudomonas infections, particularly in research settings where contaminated water systems have caused outbreaks, with lessons learned applying to pet situations. Gerbils and other small rodents occasionally develop infections. Across all species, immunocompromised individuals, those with concurrent illness, and animals in suboptimal environmental conditions face elevated risk.

Related Conditions

Commonly co-occurring conditions with Pseudomonas infections include other bacterial infections and conditions that predispose to secondary infection. Mixed bacterial infections with Staphylococcus, Streptococcus, or other organisms may occur alongside Pseudomonas, particularly in wound infections or chronic ear disease. Underlying skin conditions including wounds, abrasions, and dermatitis provide entry points for Pseudomonas and may persist after bacterial treatment. Ear mite infestations may predispose to bacterial otitis including Pseudomonas. Respiratory infections from other pathogens may occur concurrently or predispose to secondary Pseudomonas infection. Immunosuppression from various causes increases susceptibility to Pseudomonas while simultaneously affecting other infectious disease susceptibility.

Conditions with similar clinical presentation require differentiation from Pseudomonas infection. Ear infections from other bacterial species, yeast, or ear mites produce similar clinical signs to Pseudomonas otitis. Skin infections from other bacteria, fungi including dermatophytes, or parasites may appear similar to Pseudomonas skin disease. Respiratory infections have multiple potential causes beyond Pseudomonas. The characteristic blue-green pigmentation of Pseudomonas aeruginosa discharge, when present, helps distinguish this organism clinically, but culture provides definitive identification and essential sensitivity information. Mixed infections with multiple organisms require comprehensive treatment addressing all identified pathogens.

Secondary complications of Pseudomonas infections extend disease impact beyond the primary infection site. Chronic ear infections may progress to middle and inner ear involvement causing vestibular disease with permanent balance deficits. Deep tissue extension and abscess formation may complicate skin infections. Septicemia from any primary site carries high mortality risk. Antibiotic-associated complications including gastrointestinal disturbance may result from necessary treatment. Chronic infections cause ongoing stress and may secondarily impair immune function, potentially increasing susceptibility to other diseases. Treatment-resistant infection may develop through acquisition of additional resistance mechanisms during therapy, particularly with inadequate dosing or premature treatment discontinuation.